The comments come after the National Regulatory Authority of India (NRAI) was recently given the maximum ratings by the World Health Organization (WHO) for vaccine regulations.
"Grading which WHO has done now basically means India is recognised universally for having a robust regulatory mechanism. Any country which is recognised with a good regulatory mechanism becomes critical to pharmaceutical sector exporting, devices being produced and all other such activities.
"Apart from that fact, it also raises confidence about the country and its regulatory mechanism across the world," Union Health Secretary C K Mishra said.
In five categories, India's rating was four, and in four categories, it was three plus.
"Last time, we had just three rating in almost all the categories," he said.
The WHO completed the assessment of the status of the Indian vaccine regulatory system against WHO NRA Global Benchmarking Tool (GBT) and measured the maturity of the system in India.
The assessment has been done in respect of nine different functionalities and Indian NRA has been declared functional with a maturity level of 4 which is the highest level as per currently evolved definitions in respect of 5 functions, and maturity level 3 in respect of 4 functions.
A fully functional NRA is a pre-requisite for WHO pre-qualification of vaccines and one of the requirements to become eligible and retain pre-qualification status is to have the National Regulatory Authority (NRA) assessed as functional against the WHO published NRA indicators.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
